The immune response requires major changes to metabolic processes, and indeed, energy metabolism and functional activation are fully integrated in immune cells to determine their ability to divide, differentiate, and carry out effector functions. Immune cell metabolism has therefore become an attractive target area for therapeutic purposes. A neglected aspect in the translation of immunometabolism is the critical connection between systemic and cellular metabolism. Here, we discuss the importance of understanding and manipulating the integration of systemic and immune cell metabolism through in-depth analysis of immune cell phenotype and function in human metabolic diseases and, in parallel, of the effects of conventional metabolic drugs on immune cell differentiation and function. We examine how the recent identification of selective metabolic programs operating in distinct immune cell subsets and functions has the potential to deliver tools for cell- and function-specific immunometabolic targeting.

The cellular and molecular basis of translational immunometabolism / G.D. Norata, G. Caligiuri, T. Chavakis, G. Matarese, M.G. Netea, A. Nicoletti, L.A.J. O'Neill, F.M. Marelli Berg. - In: IMMUNITY. - ISSN 1074-7613. - 43:3(2015 Sep 15), pp. 3167.421-3167.434.

The cellular and molecular basis of translational immunometabolism

G.D. Norata
;
2015

Abstract

The immune response requires major changes to metabolic processes, and indeed, energy metabolism and functional activation are fully integrated in immune cells to determine their ability to divide, differentiate, and carry out effector functions. Immune cell metabolism has therefore become an attractive target area for therapeutic purposes. A neglected aspect in the translation of immunometabolism is the critical connection between systemic and cellular metabolism. Here, we discuss the importance of understanding and manipulating the integration of systemic and immune cell metabolism through in-depth analysis of immune cell phenotype and function in human metabolic diseases and, in parallel, of the effects of conventional metabolic drugs on immune cell differentiation and function. We examine how the recent identification of selective metabolic programs operating in distinct immune cell subsets and functions has the potential to deliver tools for cell- and function-specific immunometabolic targeting.
Settore BIO/14 - Farmacologia
Settore MED/04 - Patologia Generale
15-set-2015
Article (author)
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S1074761315003568-main.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 790.81 kB
Formato Adobe PDF
790.81 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I metadati presenti in AIR sono rilasciati con licenza CCO mentre i file delle pubblicazioni sono rilasciati con licenza CC BY-SA, salvo diversa indicazione. In caso di violazione di copyright, contattare l'assistenza di AIR

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/320675
Citazioni
  • ???jsp.display-item.citation.pmc??? 121
  • Scopus 172
  • ???jsp.display-item.citation.isi??? 165
  • OpenAlex ND
social impact